IPO Traffic: Week Ending Feb. 7, 2014

  Lead Manager/ # of Price Range   Dollar SCOOP
New Filings (Proposed Symbol) Joint-Lead Managers Shares Low High Volume Ratings
Antero Midstream Partners LP  (AM) Barclays/ Citigroup/ Wells Fargo Securities     $500.00 n.a.
Bio Blast Pharma Ltd. (TBA) Aegis Capital Corp       $37.50 n.a.
Diamond S Shipping Group  (DSG) Jefferies/ BofA Merrill Lynch       $100.00 n.a.
Dipexium Pharmaceuticals  (DPRX) Oppenheimer & Co.       $34.50 n.a.
Galmed Pharmaceuticals Ltd.  (GLMD) Maxim Group LLC       $34.50 n.a.
Rubicon Project (The) (RUBI) Morgan Stanley/ Goldman Sachs/ RBC Capital Markets, LLC   $100.00 n.a.
n.a. (not available)            
             
Postponed            
None            
             
Withdrawn            
Grassmere Acquisition  (TBA) Lazard Capital Markets 5.00 $10.00 $10.00 $50.00 1-Star
             
New Terms            
Auspex Pharmaceuticals  (ASPX) Stifel/ BMO Capital Markets 5.50 $10.00 $12.00 $60.50 2-Stars
Boulevard Acquisition  (BLVDU) Citigroup 15.00 $10.00 $10.00 $150.00 1-Star
Concert Pharmaceuticals  (CNCE) UBS Investment Bank/ Wells Fargo Securities 5.00 $12.00 $14.00 $65.00 2-Stars
Inogen (INGN) J.P. Morgan/ Leerink Swann 4.41 $16.00 $18.00 $75.00 2-Stars
Installed Building Products (IBP) Deutsche Bank Securities/ UBS Investment Bank 9.00 $14.00 $16.00 $135.00 1-Star
Sundance Energy Australia Limited (SEA) Wells Fargo Securities/ Canaccord Genuity/ UBS Investment Bank 7.75 $16.50 $18.50 $135.63 N/C
N/C – The ordinary shares are listed on the Australian Securities Exchange         
             
IPOs Priced Lead Shares Amount Offer Close %
Week of Feb. 3, 2014 Manager(s) Offered Raised Price 2/7/14 Change
Revance Therapeutics (RVNC) Cowen and Company/ Piper Jaffray 6.00 $96.00 $16.00 $28.00 75.00%
Auspex Pharmaceuticals  (ASPX) Stifel/ BMO Capital Markets 7.00 $84.00 $12.00 $17.65 47.08%
Continental Building Products (CBPX) Citigroup/ Credit Suisse/ Barclays/ Deutsche Bank Securities/ RBC Capital Markets 11.77 $164.71 $14.00 $17.30 23.57%
Eleven Biotherapeutics (EBIO) Citigroup/ Cowen and Company/ Leerink Swann 5.00 $50.00 $10.00 $11.15 11.50%
CM Finance (CMFN) Raymond James/ Keefe, Bruyette & Woods (A Stifel Company)/ Oppenheimer 6.67 $100.00 $15.00 $15.95 6.33%
Ladder Capital (LADR) Deutsche Bank Securities/ Citigroup/ Wells Fargo Securities/ BofA Merrill Lynch/ J.P. Morgan 13.25 $225.25 $17.00 $17.30 1.76%
Egalet   (EGLT) Stifel/ JMP Securities 4.20 $50.40 $12.00 $12.00 0.00%
Argos Therapeutics  (ARGS) Piper Jaffray/ Stifel/ JMP Securities 5.63 $45.00 $8.00 $8.00 0.00%
GeoPark Ltd (GPRK) J.P. Morgan/ BTG Pactual/ Itaú BBA 13.50 $94.50 $7.00 $6.45 -7.86%
Genocea Biosciences (GNCA) Citigroup/ Cowen and Company 5.50 $66.00 $12.00 $11.04 -8.00%
Biocept  (BIOC ) Aegis Capital 1.90 $19.00 $10.00 $8.90 -11.00%
uniQure B.V.   (QURE) Jefferies/ Leerink Swann 5.40 $91.80 $17.00 $14.79 -13.00%